12. Stockholders' equity:

Under the 2007 Equity Incentive Plan (the 2007 Plan) as amended in August 2010, 29 million shares have been authorized to be issued to employees of the Company and its subsidiaries at prices not less than the fair market value of the common stock at the date of grant. The 2007 Plan provides for the granting of incentive and nonqualified stock options, restricted stock, stock appreciation rights and stock equivalent units. These awards generally vest in three to five years. Stock option grants may be exercisable for up to ten years from the date of issuance.

The following table summarizes information about stock options outstanding at March 31, 2013:

		Options outstanding						Options exercisable
Range of exercise prices		Number outstanding		Weighted average remaining contractual life (in years)		Weighted average exercise price		Number exercisable		Weighted average exercise price

$	20.55 to $30.00		4,520		7.5	$	27.83		1,793	$	26.53
	30.01 to 50.00		10,054		6.7		34.87		5,034		36.52
	50.01 to 59.05		977		2.4		54.05		977		54.05
			15,551		6.7		34.03		7,804		36.42

Transactions under the stock option plan are summarized as follows:

(In thousands)	Shares			Weighted average exercise price		Weighted average remaining contractual life (in years)	Aggregate intrinsic value
Stock options:
Outstanding at March 31, 2010 (at $20.55 to $63.44 per share)		18,701		$	38.05
Granted (at $26.18 to $32.28 per share)		3,241			31.14
Exercised (at $20.55 to $31.27 per share)		( 115	)		25.17
Forfeited and Expired		( 4,742	)		37.79

Outstanding at March 31, 2011 (at $20.55 to $63.44 per share)		17,085		$	36.90
Granted (at $30.00 to $34.49 per share)		3,758			31.04
Exercised (at $20.55 to $39.88 per share)		( 351	)		28.19
Forfeited and Expired		( 3,249	)		39.89

Outstanding at March 31, 2012 (at $20.55 to $59.05 per share)		17,243		$	35.24
Granted (at $34.04 to $38.10 per share)		2,368			34.26
Exercised (at $31.28 to $38.45 per share)		( 1,137	)		28.52
Forfeited and Expired		( 2,923	)		43.70

Outstanding at March 31, 2013 (at $20.55 to $59.05 per share)		15,551		$	34.03	6.7	$82,456

Exercisable at March 31, 2013		7,804		$	36.42	5.2	$32,792

	Restricted Stock					Performance Stock Units
	Shares			Weighted average grant date fair value		Shares		Weighted average grant date fair value
Restricted stock:
Outstanding at March 31, 2010		1,886		$	29.46
Granted		1,272			31.82
Vested		( 777	)		29.61
Forfeited		( 106	)		29.88

Outstanding at March 31, 2011		2,275		$	30.72
Granted		1,239			30.43
Vested		( 928	)		30.66
Forfeited		( 101	)		30.62

Outstanding at March 31, 2012		2,485		$	30.60		-		-
Granted		613			34.27		410	$	36.12
Vested		( 1,047	)		30.13		-		-
Forfeited		( 88	)		31.86		-		-

Outstanding at March 31, 2013		1,963		$	31.96		410	$	36.12

At March 31, 2013, 7.7 million shares were available for grant.

The total intrinsic value of stock options exercised during the years ended March 31, 2013, 2012 and 2011 was $8.7 million, $2.5 million and $0.8 million, respectively, and the total intrinsic value of restricted

stock vested during the years ended March 31, 2013, 2012 and 2011 was $37.5 million, $28.6 million and $24.3 million, respectively. The weighted average grant date fair value per stock option granted during

the years ended March 31, 2013, 2012 and 2011 were $10.04, $9.68 and $10.00, respectively. The total cash received as a result of stock option exercises for the years ended March 31, 2013, 2012 and 2011 was approximately $32.0 million, $9.9 million and $2.9 million, respectively. In connection with these exercises, the Company recorded a net tax benefit of $1.8 million for the year ended March 31, 2013, a

net tax benefit of $0.02 million for the year ended March 31, 2012 and a net tax provision of $0.7 million, for the year ended March 31, 2011. The Company settles employee stock option exercises and restricted stock releases with newly issued common shares.

On August 27, 2012, the Company's Board of Directors adopted a stockholders' rights plan (Rights Plan) and declared a dividend distribution of one preferred share purchase right (Right) on each share of the Company's common stock, par value $.10 per share, outstanding on September 7, 2012. Each Right will entitle the holder to buy one thousandth of a share of authorized Series B Junior Participating Preferred Stock, par value $1.00 per share (Series B Preferred Stock) at an exercise price of $100, once the Rights become exercisable. In general the Rights will be exercisable only if a person or group acquires 12% (or 20% in the case of a "13G Institutional Investor", as defined in the Rights plan) or more of the Company's common stock. Prior to becoming exercisable, the Rights are redeemable for $.001 per Right at the option of the Board of Directors. The Rights will expire in August 2013 unless the Rights Plan is ratified by the Company's stockholders.